Cargando…
Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer
Chemotherapy for aggressive non-small-cell lung cancer (NSCLC) usually results in a poor prognosis due to tumor metastasis, vasculogenic mimicry (VM) channels, limited killing of tumor cells, and severe systemic toxicity. Herein, we developed a kind of multifunctional targeting epirubicin liposomes...
Autores principales: | Song, Xiao-li, Ju, Rui-jun, Xiao, Yao, Wang, Xin, Liu, Shuang, Fu, Min, Liu, Jing-jing, Gu, Li-yan, Li, Xue-tao, Cheng, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644542/ https://www.ncbi.nlm.nih.gov/pubmed/29066893 http://dx.doi.org/10.2147/IJN.S141787 |
Ejemplares similares
-
RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply
por: Kong, Liang, et al.
Publicado: (2020) -
Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
Publicado: (2021) -
Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
por: Kong, Dehua, et al.
Publicado: (2022) -
The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals
por: Men, Ying, et al.
Publicado: (2011) -
The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
por: Liu, Lei, et al.
Publicado: (2017)